FDA Adverse Event Injury Summary report: N

ENTERYX PROCEDURE KIT

MDR report key: 1333204 · Received March 5, 2009

Report

Report Number
3005099803-2008-01924
Event Type
Injury
Date Received
March 5, 2009
Date of Event
August 4, 2005
Report Date
August 15, 2005
Manufacturer
BOSTON SCIENTIFIC CORPORATION- MARLBOROUGH
Product Code
LMN
PMA / PMN Number
P020006
Removal / Correction Number
Z-0040-06
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE REMAINS IMPLANTED IN THE PATIENT; THEREFORE, A DEVICE EVALUATION CANNOT BE PERFORMED. NOTE: THIS PRODUCT WAS REMOVED FROM THE GLOBAL MARKET IN SEPTEMBER 2005. BOSTON SCIENTIFIC CORPORATION NO LONGER PRODUCES THE REPORTED PRODUCT.

Description of Event or Problem · 1

IT WAS REPORTED TO BOSTON SCIENTIFIC CORPORATION ON AUGUST 15, 2005 THAT AN ENTERYX PROCEDURE KIT WAS IMPLANTED IN A PATIENT IN 2005 (PATIENT AGE, GENDER AND WEIGHT ARE UNKNOWN). EIGHT INJECTIONS WERE PERFORMED, DELIVERING A TOTAL OF 6.0CC'S OF ENTERYX SOLUTION TO THE PATIENT . OF THE TOTAL SOLUTION DELIVERED, 2.8CC'S WERE INJECTED SUBMUCOSALLY. ACCORDING TO THE COMPLAINANT, THE PATIENT EXPERIENCED BLEEDING FROM THE INJECTION SITE OF MILD INTENSITY ON THE DAY OF THE PROCEDURE. THE PATIENT WAS TREATED WITH AN INJECTION OF 8.0CC'S OF EPINEPHRINE INJECTED INTO THE BLEEDING SITE AND THE BLEEDING HAD RESOLVED BEFORE THE SCOPE WAS REMOVED FROM THE SITE. THE PATIENT WAS REPORTED TO BE DOING FINE AND NO DILATIONS WERE REQUIRED. NO WEIGHT LOSS WAS REPORTED BY THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENTERYX PROCEDURE KIT CERAMICS, CALCIUM TRIPHOSPHATE/HYDROXYPATITE, NON-LOAD BEARING USES LMN BOSTON SCIENTIFIC CORPORATION- MARLBOROUGH M00572600 40611

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention